Stocks:
5,472
ETFs:
2,400
Exchanges:
11
Market Cap:
$58.99T
24h Vol:
$10.08B
Dominance:
MSFT:5.13%
Stocklytics Platform
BETA
Instrument logo  ABT

Abbott Laboratories

ABT
58 / 100
S&P500
$119.40arrow_drop_up0.59%$0.71
Key Stats
Open$119.50
Prev. Close$119.46
EPS3.26
Dividend$2.08
Next Earnings DateAug 13, 2024
Dividend Yield %1.84%
Market Cap$205.94B
PE Ratio36.41
LOWHIGH
Day Range118.39
119.95
52 Week Range89.67
120.15
Ratios
P/B Ratio5.37
Revenue$40.10B
Operating M. %20.09%
Earnings$5.72B
Earnings Growth %-17.45%
EBITDA Margin %26.09%
ROE %15.11%
EPS3.26
Fundamentals
RPS$23.05
Gross Profit$22.23B
EBITDA$10.58B
Total Debt$15.87B
P/S Ratio5.1x
Enterprise to EBITDA20.45
Profit Margin14.27%
ROA6.11%
Debt/Equity Ratio0.41%
Payout Ratio46.85%
Industry average yield3.05%
Last Dividend pay dateMay 15, 2024
Dividend per share$2.08
Dividend yield forecast0.02%

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell
Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

ABTarrow_drop_up0.37%
US Healthcare Sectorarrow_drop_up0.65%
US Marketarrow_drop_up0.51%
ABT / Market
ABT lose to the US Market which returned 0.51% over the last twenty four hours.
ABT / Healthcare Sector
ABT lose to the US Healthcare sector which returned 0.65% over the last twenty four hours.

Abbott Laboratories (ABT) Statistics

Abbott Laboratories (ABT) is a leading global healthcare company that specializes in the development and manufacturing of medical devices, diagnostics, and pharmaceuticals. The company was founded in 1888 and has since grown into a diverse organization with a presence in over 160 countries worldwide. Abbott Laboratories is headquartered in Abbott Park, Illinois, and operates through four main segments: Established Pharmaceuticals, Nutrition, Diagnostics, and Medical Devices.

When it comes to statistics, Abbott Laboratories has consistently shown strong financial performance over the years. The company's valuation metrics reveal a solid investment opportunity. ABT stock has a forward P/E ratio of 24.56, indicating that investors are willing to pay a premium for the company's future earnings potential. Additionally, ABT has a price-to-sales ratio of 4.71, which is considered favorable compared to the industry average. These metrics suggest that Abbott Laboratories is a financially healthy and attractive investment option.

add Abbott Laboratories to watchlist

Keep an eye on Abbott Laboratories

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
question_mark
How has Abbott Laboratories (ABT) stock's performance compared to its sector and the market over the past year?

Over the past year, Abbott Laboratories (ABT) has experienced a price change of 19.75%. Compared to the Healthcare sector, which saw a change of 35.20%, Abbott Laboratories has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 39.12%, it has fallen short of the market average. This comparison highlights Abbott Laboratories's performance relative to both its sector and the overall market over the last year.

question_mark
What is the PE ratio of Abbott Laboratories (ABT) stock?

The PE (Price to Earnings) ratio of Abbott Laboratories (ABT) is currently 36.64. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.

question_mark
What is the EPS of Abbott Laboratories (ABT) stock?

The Earnings Per Share (EPS) for Abbott Laboratories (ABT), calculated on a diluted basis, is $3.26. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.

question_mark
What is the operating margin of Abbott Laboratories (ABT) stock?

The operating margin for Abbott Laboratories (ABT) is 20.09%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.

question_mark
What is the EBITDA of Abbott Laboratories (ABT) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Abbott Laboratories (ABT) is $10.58B. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.

question_mark
How much debt does Abbott Laboratories (ABT) have?

Abbott Laboratories (ABT) has a total debt of $15.87B. The net debt, which accounts for cash and cash equivalents against the total debt, is $7.05B.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.